Monitoring Bacterial Meningitis after Introducing Vaccines for S. Pneumoniae, H. Influenza Type B and N. Meningitidis A in Cameroon
HUG project leader Pr Alain Gervaix, Dr Beat Stoll
Department, division Department of Children and Adolescent, Division of Pediatric Emergency
e-mail alain.gervaix@hcuge.ch
Country partner Cameroon
Project partner abroad Dr Jean Taguebue
Department, division
Institution Child and Mother Hospital, Chantal Byia Foundation Yaounde
e-mail
Starting date 2012
Ending date Ongoing
Bacterial meningitis is responsible for a high mortality and morbidity in Cameroon, which is why vaccines against S. Pneumoniae, H. Influenza type B and N. Meningitidis sg A, were recently introduced into this country with the help of the GAVI alliance. However, in a previous study done in this country, we demonstrated that only 62% of the S. Pneumoniae serotypes in Cameroon are covered by the vaccine, causing uncertainty about the impact of this vaccine in the country (Gervaix A and al. Pediatr Infect Dis J, 2012 in press). The purpose of this study consists of establishing a surveillance network for bacterial meningitis in Cameroon, measuring the vaccination impact and monitoring the S. Pneumoniae serotypes.

 

 

Download “Bacterial Meningitis And Pneumococcal Serotype Distribution In Children In Cameroon” MeningiteCAm.pdf – Downloaded 437 times – 141 KB


Download “Protocole d'étude” Protocole-MenOcam.pdf – Downloaded 377 times – 233 KB


Download “Soutien du ministère de la santé” Soutien-MinSan.pdf – Downloaded 353 times – 206 KB